Tofacitinib versus Methotrexate in Rheumatoid Arthritis

被引：11
作者：
Sexton, Donal [1 ]
机构：
[1] Natl Univ Ireland, Galway, Ireland
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2014年 / 371卷 / 12期
关键词：
RENAL-FUNCTION; DISEASE;
D O I：
10.1056/NEJMc1408607
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1163 / 1163
页数：1
相关论文
共 50 条
  • [1] Tofacitinib versus Methotrexate in Rheumatoid Arthritis
    Lee, Eun Bong
    Fleischmann, Roy
    Hall, Stephen
    Wilkinson, Bethanie
    Bradley, John D.
    Gruben, David
    Koncz, Tamas
    Krishnaswami, Sriram
    Wallenstein, Gene V.
    Zang, Chuanbo
    Zwillich, Samuel H.
    van Vollenhoven, Ronald F.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (25) : 2377 - 2386
  • [2] Efficacy and safety of tofacitinib combined with methotrexate in the treatment of rheumatoid arthritis: A systematic review and meta-analysis
    Gao, Yan
    Gao, Yi-ni
    Wang, Mei-jiao
    Zhang, Yi
    Zhang, Feng-qi
    He, Zhi-xing
    Chen, Wu
    Li, Hai-chang
    Xie, Zhi-jun
    Wen, Cheng-ping
    HELIYON, 2023, 9 (05)
  • [3] Tofacitinib Prevents Radiographic Progression in Rheumatoid Arthritis
    Kim, Joon Wan
    Choi, In Ah
    Lee, Eun Young
    Song, Yeong Wook
    Lee, Eun Bong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2013, 28 (08) : 1134 - 1138
  • [4] Achieving pain control in early rheumatoid arthritis with baricitinib monotherapy or in combination with methotrexate versus methotrexate monotherapy
    Taylor, Peter C.
    Alten, Rieke
    Gracia, Jose Maria Alvaro
    Kaneko, Yuko
    Walls, Chad
    Quebe, Amanda
    Jia, Bochao
    Bello, Natalia
    Terres, Jorge Ross
    Fleischmann, Roy
    RMD OPEN, 2022, 8 (01):
  • [5] Lymphoma in the Tofacitinib Rheumatoid Arthritis Clinical Development Program
    Mariette, Xavier
    Chen, Connie
    Biswas, Pinaki
    Kwok, Kenneth
    Boy, Mary G.
    ARTHRITIS CARE & RESEARCH, 2018, 70 (05) : 685 - 694
  • [6] A pharmacokinetic and clinical assessment of tofacitinib for the treatment of rheumatoid arthritis
    Bannwarth, Bernard
    Kostine, Marie
    Poursac, Nicolas
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (06) : 753 - 761
  • [7] Targeting the Janus kinases in rheumatoid arthritis: focus on tofacitinib
    Yamaoka, Kunihiro
    Tanaka, Yoshiya
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (01) : 103 - 113
  • [8] The effect of tofacitinib on residual Open pain in patients with rheumatoid arthritis and psoriatic arthritis
    Dougados, Maxime
    Taylor, Peter C.
    Bingham, Clifton O., III
    Fallon, Lara
    Brault, Yves
    Roychoudhury, Satrajit
    Wang, Lisy
    Kessouri, Meriem
    RMD OPEN, 2022, 8 (02):
  • [9] Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib
    Bird, Paul
    Hall, Stephen
    Nash, Peter
    Connell, Carol A.
    Kwok, Kenneth
    Witcombe, David
    Thirunavukkarasu, Krishan
    RMD OPEN, 2019, 5 (01):
  • [10] Potential Mechanisms Leading to the Abnormal Lipid Profile in Patients With Rheumatoid Arthritis Versus Healthy Volunteers and Reversal by Tofacitinib
    Charles-Schoeman, Christina
    Fleischmann, Roy
    Davignon, Jean
    Schwartz, Howard
    Turner, Scott M.
    Beysen, Carine
    Milad, Mark
    Hellerstein, Marc K.
    Luo, Zhen
    Kaplan, Irina V.
    Riese, Richard
    Zuckerman, Andrea
    McInnes, Iain B.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (03) : 616 - 625
12345